"Approval Date","Drug Name","Submission","Active Ingredients","Company","Submission Classification *","Submission Status"
"12/01/2022","UNISOMNDA   #018066","SUPPL-21","DOXYLAMINE SUCCINATE","CHATTEM","Labeling","Approval"
"12/01/2022","LOVENOXNDA   #020164","SUPPL-131","ENOXAPARIN SODIUM","SANOFI AVENTIS US","Labeling","Approval"
"12/01/2022","LOVENOX (PRESERVATIVE FREE)NDA   #020164","SUPPL-131","ENOXAPARIN SODIUM","SANOFI AVENTIS US","Labeling","Approval"
"12/01/2022","BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEANDA  #079106","SUPPL-30","BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE","UNICHEM","Labeling","Approval"
"12/01/2022","BIMATOPROSTANDA  #090449","SUPPL-8","BIMATOPROST","APOTEX","Labeling","Approval"
"12/01/2022","BIMATOPROSTANDA  #202565","SUPPL-1","BIMATOPROST","SANDOZ INC","Labeling","Approval"
"12/01/2022","BIMATOPROSTANDA  #202565","SUPPL-2","BIMATOPROST","SANDOZ INC","Labeling","Approval"
"12/01/2022","ESTRADIOLANDA  #206241","ORIG-1","ESTRADIOL","ZYDUS NOVELTECH INC","","Approval"
"12/01/2022","TERIFLUNOMIDEANDA  #209549","SUPPL-1","TERIFLUNOMIDE","WATSON LABS TEVA","Labeling","Approval"
"12/01/2022","TERIFLUNOMIDEANDA  #209549","SUPPL-2","TERIFLUNOMIDE","WATSON LABS TEVA","Labeling","Approval"
"12/01/2022","APIXABANANDA  #210180","SUPPL-1","APIXABAN","ACCORD HLTHCARE","Labeling","Approval"
"12/01/2022","SUNOSINDA   #211230","SUPPL-7","SOLRIAMFETOL HYDROCHLORIDE","AXSOME MALTA","Labeling","Approval"
"12/01/2022","REZLIDHIANDA   #215814","ORIG-1","OLUTASIDENIB","RIGEL PHARMS INC","Type 1 - New Molecular Entity","Approval"
"12/02/2022","RISPERDALNDA   #020272","SUPPL-87","RISPERIDONE","JANSSEN PHARMS","Labeling","Approval"
"12/02/2022","RISPERDALNDA   #021444","SUPPL-59","RISPERIDONE","JANSSEN PHARMS","Labeling","Approval"
"12/02/2022","POTASSIUM CHLORIDEANDA  #080205","SUPPL-104","POTASSIUM CHLORIDE","HOSPIRA","Labeling","Approval"
"12/02/2022","POTASSIUM CHLORIDEANDA  #083163","SUPPL-26","POTASSIUM CHLORIDE","INTL MEDICATION","Labeling","Approval"
"12/02/2022","POTASSIUM CHLORIDEANDA  #085870","SUPPL-39","POTASSIUM CHLORIDE","B BRAUN","Labeling","Approval"
"12/02/2022","PREDNISONEANDA  #088832","SUPPL-44","PREDNISONE","MYLAN PHARMS","Manufacturing (CMC)","Approval"
"12/02/2022","POTASSIUM CHLORIDE IN PLASTIC CONTAINERANDA  #088901","SUPPL-40","POTASSIUM CHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"12/02/2022","POTASSIUM CHLORIDE IN PLASTIC CONTAINERANDA  #088908","SUPPL-37","POTASSIUM CHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"12/02/2022","ARIPIPRAZOLEANDA  #090165","SUPPL-3","ARIPIPRAZOLE","SQUARE PHARMS","Labeling","Approval"
"12/02/2022","ARIPIPRAZOLEANDA  #090165","SUPPL-4","ARIPIPRAZOLE","SQUARE PHARMS","Labeling","Approval"
"12/02/2022","QUDEXY XRNDA   #205122","SUPPL-14","TOPIRAMATE","UPSHER SMITH LABS","Labeling","Approval"
"12/02/2022","OLMESARTAN MEDOXOMILANDA  #206720","ORIG-1","OLMESARTAN MEDOXOMIL","PRINSTON INC","","Approval"
"12/02/2022","TRELEGY ELLIPTANDA   #209482","SUPPL-16","FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE","GLAXOSMITHKLINE","Labeling","Approval"
"12/02/2022","ESMOLOL HYDROCHLORIDEANDA  #214172","ORIG-1","ESMOLOL HYDROCHLORIDE","HQ SPCLT PHARMA","","Approval"
"12/02/2022","AMLODIPINE BENZOATEANDA  #215035","ORIG-1","AMLODIPINE BENZOATE","AMNEAL PHARMS LLC","","Tentative Approval"
"12/02/2022","CARBAMAZEPINEANDA  #216404","ORIG-1","CARBAMAZEPINE","RICONPHARMA LLC","","Approval"
"12/02/2022","TECENTRIQBLA   #761034","SUPPL-50","ATEZOLIZUMAB","GENENTECH INC","","Approval"
"12/05/2022","SPORANOXNDA   #020083","SUPPL-65","ITRACONAZOLE","JANSSEN PHARMS","Labeling","Approval"
"12/05/2022","SPORANOXNDA   #020657","SUPPL-38","ITRACONAZOLE","JANSSEN PHARMS","Labeling","Approval"
"12/05/2022","FUROSEMIDEANDA  #075241","SUPPL-15","FUROSEMIDE","HOSPIRA","Labeling","Approval"
"12/05/2022","FUROSEMIDEANDA  #075241","SUPPL-16","FUROSEMIDE","HOSPIRA","Labeling","Approval"
"12/05/2022","SERTRALINE HYDROCHLORIDEANDA  #077670","SUPPL-35","SERTRALINE HYDROCHLORIDE","LUPIN","Manufacturing (CMC)","Approval"
"12/05/2022","ARIPIPRAZOLEANDA  #090165","SUPPL-6","ARIPIPRAZOLE","SQUARE PHARMS","Manufacturing (CMC)","Approval"
"12/05/2022","BLINCYTOBLA   #125557","SUPPL-25","BLINATUMOMAB","AMGEN","","Approval"
"12/05/2022","LATANOPROSTANDA  #201786","SUPPL-6","LATANOPROST","SOMERSET","Labeling","Approval"
"12/05/2022","TRODELVYBLA   #761115","SUPPL-31","SACITUZUMAB GOVITECAN-HZIY","IMMUNOMEDICS INC","","Approval"
"12/06/2022","WELLBUTRINNDA   #018644","SUPPL-59","BUPROPION HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling","Approval"
"12/06/2022","WELLBUTRIN SRNDA   #020358","SUPPL-66","BUPROPION HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling","Approval"
"12/06/2022","MYOVIEWNDA   #020372","SUPPL-33","TECHNETIUM TC-99M TETROFOSMIN KIT","GE HEALTHCARE","Labeling","Approval"
"12/06/2022","MYOVIEW 30MLNDA   #020372","SUPPL-33","TECHNETIUM TC-99M TETROFOSMIN KIT","GE HEALTHCARE","Labeling","Approval"
"12/06/2022","SANCUSONDA   #022198","SUPPL-19","GRANISETRON","KYOWA KIRIN","Manufacturing (CMC)","Approval"
"12/06/2022","DUAVEENDA   #022247","SUPPL-7","BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED","WYETH PHARMS","Labeling","Approval"
"12/06/2022","CALDOLORNDA   #022348","SUPPL-20","IBUPROFEN","CUMBERLAND PHARMS","Labeling","Approval"
"12/06/2022","KETOROLAC TROMETHAMINEANDA  #074754","SUPPL-22","KETOROLAC TROMETHAMINE","TEVA","Labeling","Approval"
"12/06/2022","POTASSIUM CHLORIDEANDA  #085870","SUPPL-38","POTASSIUM CHLORIDE","B BRAUN","Labeling","Approval"
"12/06/2022","NAFCILLIN SODIUMANDA  #090560","SUPPL-7","NAFCILLIN SODIUM","ANTIBIOTICE","Labeling","Approval"
"12/06/2022","VASOSTRICTNDA   #204485","SUPPL-27","VASOPRESSIN","PAR STERILE PRODUCTS","Labeling","Approval"
"12/06/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205299","SUPPL-12","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","DR REDDYS LABS SA","Labeling","Approval"
"12/06/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205806","SUPPL-11","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","DR REDDYS LABS SA","Labeling","Approval"
"12/06/2022","VILAZODONE HYDROCHLORIDEANDA  #208200","ORIG-2","VILAZODONE HYDROCHLORIDE","INVAGEN PHARMS","","Approval"
"12/06/2022","SODIUM FLUORIDE F-18ANDA  #216126","ORIG-1","SODIUM FLUORIDE F-18","BAMF","","Approval"
"12/06/2022","TEPEZZABLA   #761143","SUPPL-21","TEPROTUMUMAB-TRBW","HORIZON THERAPEUTICS IRELAND","","Approval"
"12/07/2022","SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #020178","SUPPL-31","SODIUM CHLORIDE","BAXTER HLTHCARE","Manufacturing (CMC)","Approval"
"12/07/2022","DEXTROSE 5% IN PLASTIC CONTAINERNDA   #020179","SUPPL-26","DEXTROSE","BAXTER HLTHCARE","Manufacturing (CMC)","Approval"
"12/07/2022","LIPITORNDA   #020702","SUPPL-79","ATORVASTATIN CALCIUM","UPJOHN","Labeling","Approval"
"12/07/2022","BENDAMUSTINE HYDROCHLORIDEANDA  #205376","ORIG-1","BENDAMUSTINE HYDROCHLORIDE","DR REDDYS","","Approval"
"12/07/2022","BENDAMUSTINE HYDROCHLORIDEANDA  #205574","ORIG-1","BENDAMUSTINE HYDROCHLORIDE","ACCORD HLTHCARE","","Approval"
"12/07/2022","TRIPTODUR KITNDA   #208956","SUPPL-9","TRIPTORELIN PAMOATE","AZURITY","Labeling","Approval"
"12/07/2022","POLYETHYLENE GLYCOL 3350ANDA  #209017","SUPPL-1","POLYETHYLENE GLYCOL 3350","AUROBINDO PHARMA LTD","Labeling","Approval"
"12/07/2022","POLYETHYLENE GLYCOL 3350ANDA  #209017","SUPPL-2","POLYETHYLENE GLYCOL 3350","AUROBINDO PHARMA LTD","Labeling","Approval"
"12/07/2022","ESLICARBAZEPINE ACETATEANDA  #211199","ORIG-1","ESLICARBAZEPINE ACETATE","ALKEM LABS LTD","","Tentative Approval"
"12/07/2022","VIVIMUSTANDA   #212209","ORIG-1","BENDAMUSTINE HYDROCHLORIDE","SLAYBACK PHARMA LLC","Type 5 - New Formulation or New Manufacturer","Approval"
"12/07/2022","BENDAMUSTINE HYDROCHLORIDENDA   #215033","ORIG-1","BENDAMUSTINE HYDROCHLORIDE","APOTEX","Type 5 - New Formulation or New Manufacturer","Approval"
"12/07/2022","DOXYCYCLINE HYCLATEANDA  #216690","ORIG-1","DOXYCYCLINE HYCLATE","PAR STERILE PRODUCTS","","Approval"
"12/08/2022","PRED MILDNDA   #017100","SUPPL-46","PREDNISOLONE ACETATE","ABBVIE","Labeling","Approval"
"12/08/2022","PRED MILDNDA   #017100","SUPPL-48","PREDNISOLONE ACETATE","ABBVIE","Labeling","Approval"
"12/08/2022","ACTIQNDA   #020747","SUPPL-61","FENTANYL CITRATE","CEPHALON","REMS","Approval"
"12/08/2022","LEVEMIRBLA   #021536","SUPPL-62","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","","Approval"
"12/08/2022","LEVEMIR FLEXPENBLA   #021536","SUPPL-62","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","","Approval"
"12/08/2022","LEVEMIR FLEXTOUCHBLA   #021536","SUPPL-62","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","","Approval"
"12/08/2022","LEVEMIR INNOLETBLA   #021536","SUPPL-62","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","","Approval"
"12/08/2022","LEVEMIR PENFILLBLA   #021536","SUPPL-62","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","","Approval"
"12/08/2022","FENTORANDA   #021947","SUPPL-42","FENTANYL CITRATE","CEPHALON","REMS","Approval"
"12/08/2022","LAZANDANDA   #022569","SUPPL-33","FENTANYL CITRATE","BTCP PHARMA","REMS","Approval"
"12/08/2022","FENTANYL CITRATEANDA  #078907","SUPPL-25","FENTANYL CITRATE","SPECGX LLC","REMS","Approval"
"12/08/2022","FENTANYL CITRATEANDA  #079075","SUPPL-17","FENTANYL CITRATE","WATSON LABS","REMS","Approval"
"12/08/2022","SUBSYSNDA   #202788","SUPPL-30","FENTANYL","BTCP PHARMA","REMS","Approval"
"12/08/2022","PHENYLEPHRINE HYDROCHLORIDENDA   #203510","SUPPL-5","PHENYLEPHRINE HYDROCHLORIDE","PARAGON BIOTECK","Manufacturing (CMC)","Approval"
"12/08/2022","SILODOSINANDA  #204816","ORIG-1","SILODOSIN","ZYDUS PHARMS","","Approval"
"12/08/2022","FENTANYL CITRATEANDA  #206329","SUPPL-1","FENTANYL CITRATE","DR REDDYS LABS SA","REMS","Approval"
"12/08/2022","FENTANYL CITRATEANDA  #207338","SUPPL-4","FENTANYL CITRATE","ACTAVIS LABS FL INC","REMS","Approval"
"12/08/2022","ZEJULANDA   #208447","SUPPL-25","NIRAPARIB TOSYLATE","GLAXOSMITHKLINE","Efficacy","Approval"
"12/08/2022","LORATADINEANDA  #208477","SUPPL-25","LORATADINE","AUROBINDO PHARMA LTD","Efficacy","Approval"
"12/08/2022","POSACONAZOLEANDA  #214321","ORIG-1","POSACONAZOLE","HETERO LABS LTD III","","Approval"
"12/08/2022","DESONIDEANDA  #214396","ORIG-1","DESONIDE","ALEMBIC","","Approval"
"12/09/2022","DOCEFREZNDA   #022534","SUPPL-16","DOCETAXEL","SUN PHARM","Labeling","Approval"
"12/09/2022","DOCETAXELNDA   #022534","SUPPL-16","DOCETAXEL","SUN PHARM","Labeling","Approval"
"12/09/2022","PIPERACILLIN AND TAZOBACTAMANDA  #065458","SUPPL-14","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","STERISCIENCE","Labeling","Approval"
"12/09/2022","ENOXAPARIN SODIUM (PRESERVATIVE FREE)ANDA  #077857","SUPPL-41","ENOXAPARIN SODIUM","SANDOZ","Labeling","Approval"
"12/09/2022","PREGABALINANDA  #206752","ORIG-1","PREGABALIN","ZYDUS PHARMS","","Approval"
"12/09/2022","BORTEZOMIBNDA   #209191","SUPPL-3","BORTEZOMIB","HOSPIRA","Efficacy","Approval"
"12/09/2022","HYDROXYCHLOROQUINE SULFATEANDA  #210577","SUPPL-9","HYDROXYCHLOROQUINE SULFATE","AMNEAL PHARMS CO","Labeling","Approval"
"12/09/2022","HYDROXYCHLOROQUINE SULFATEANDA  #210577","SUPPL-12","HYDROXYCHLOROQUINE SULFATE","AMNEAL PHARMS CO","Labeling","Approval"
"12/09/2022","GUAIFENESINANDA  #213420","SUPPL-1","GUAIFENESIN","GRANULES","Labeling","Approval"
"12/09/2022","TRIAMCINOLONE ACETONIDEANDA  #214582","ORIG-1","TRIAMCINOLONE ACETONIDE","QUAGEN","","Approval"
"12/09/2022","TASCENSO ODTNDA   #214962","ORIG-1","FINGOLIMOD LAURYL SULFATE","CYCLE","Type 2 - New Active Ingredient","Approval"
"12/09/2022","LEVOCARNITINEANDA  #216384","ORIG-1","LEVOCARNITINE","NOVITIUM PHARMA","","Approval"
"12/09/2022","TECENTRIQBLA   #761034","SUPPL-47","ATEZOLIZUMAB","GENENTECH INC","","Approval"
"12/12/2022","INDIUM IN 111 OXYQUINOLINENDA   #019044","SUPPL-25","INDIUM IN-111 OXYQUINOLINE","GE HEALTHCARE","Labeling","Approval"
"12/12/2022","TASIMELTEONANDA  #211601","ORIG-1","TASIMELTEON","TEVA PHARMS USA INC","","Approval"
"12/12/2022","BRIMONIDINE TARTRATE AND TIMOLOL MALEATEANDA  #215598","ORIG-1","BRIMONIDINE TARTRATE; TIMOLOL MALEATE","UPSHER SMITH LABS","","Approval"
"12/12/2022","VALBENAZINEANDA  #215962","ORIG-1","VALBENAZINE","SANDOZ INC","","Tentative Approval"
"12/12/2022","KRAZATINDA   #216340","ORIG-1","ADAGRASIB","MIRATI THERAPS","Type 1 - New Molecular Entity","Approval"
"12/13/2022","ZEGERID OTCNDA   #022281","SUPPL-16","OMEPRAZOLE; SODIUM BICARBONATE","RILEY CONSUMER","Labeling","Approval"
"12/13/2022","PANTOPRAZOLE SODIUMANDA  #077674","SUPPL-8","PANTOPRAZOLE SODIUM","SUN PHARM","Labeling","Approval"
"12/13/2022","NEVIRAPINEANDA  #077702","SUPPL-17","NEVIRAPINE","AUROBINDO","Labeling","Approval"
"12/13/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091422","SUPPL-48","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ACTAVIS ELIZABETH","Labeling","Approval"
"12/13/2022","BUPROPION HYDROCHLORIDEANDA  #200216","SUPPL-1","BUPROPION HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"12/13/2022","BUPROPION HYDROCHLORIDEANDA  #200216","SUPPL-2","BUPROPION HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"12/13/2022","BUPROPION HYDROCHLORIDEANDA  #201567","SUPPL-14","BUPROPION HYDROCHLORIDE","ZYDUS PHARMS","Labeling","Approval"
"12/13/2022","BUPROPION HYDROCHLORIDEANDA  #201567","SUPPL-15","BUPROPION HYDROCHLORIDE","ZYDUS PHARMS","Labeling","Approval"
"12/13/2022","NEVIRAPINEANDA  #204621","SUPPL-6","NEVIRAPINE","ALVOGEN","Labeling","Approval"
"12/13/2022","IBRANCENDA   #207103","SUPPL-15","PALBOCICLIB","PFIZER","Efficacy","Approval"
"12/13/2022","BUPROPION HYDROCHLORIDEANDA  #210497","SUPPL-2","BUPROPION HYDROCHLORIDE","ACCORD HLTHCARE","Labeling","Approval"
"12/13/2022","BUPROPION HYDROCHLORIDEANDA  #210497","SUPPL-5","BUPROPION HYDROCHLORIDE","ACCORD HLTHCARE","Labeling","Approval"
"12/13/2022","VORICONAZOLEANDA  #211099","SUPPL-9","VORICONAZOLE","GLAND PHARMA LTD","Labeling","Approval"
"12/13/2022","VORICONAZOLEANDA  #211099","SUPPL-10","VORICONAZOLE","GLAND PHARMA LTD","Labeling","Approval"
"12/13/2022","ZYNRELEF KITNDA   #211988","SUPPL-10","BUPIVACAINE; MELOXICAM","HERON THERAPS INC","Labeling","Approval"
"12/13/2022","LURASIDONE HYDROCHLORIDEANDA  #212244","ORIG-1","LURASIDONE HYDROCHLORIDE","ALKEM LABS LTD","","Approval"
"12/13/2022","IBRANCENDA   #212436","SUPPL-3","PALBOCICLIB","PFIZER","Efficacy","Approval"
"12/13/2022","VENLAFAXINE HYDROCHLORIDEANDA  #213927","SUPPL-1","VENLAFAXINE HYDROCHLORIDE","DEXCEL","Labeling","Approval"
"12/13/2022","METHYLPHENIDATE HYDROCHLORIDEANDA  #213936","SUPPL-1","METHYLPHENIDATE HYDROCHLORIDE","ACCORD HLTHCARE","Labeling","Approval"
"12/13/2022","PEMETREXED DISODIUMANDA  #215479","ORIG-1","PEMETREXED DISODIUM","MEITHEAL","","Approval"
"12/13/2022","DICLOFENAC POTASSIUMANDA  #215585","SUPPL-1","DICLOFENAC POTASSIUM","NOVAST LABS","Labeling","Approval"
"12/13/2022","FORMOTEROL FUMARATEANDA  #215621","ORIG-1","FORMOTEROL FUMARATE","SLAYBACK PHARMA LLC","","Approval"
"12/13/2022","IYUZEHNDA   #216472","ORIG-1","LATANOPROST","THEA PHARMA","Type 5 - New Formulation or New Manufacturer","Approval"
"12/13/2022","ESMOLOL HYDROCHLORIDEANDA  #216603","ORIG-1","ESMOLOL HYDROCHLORIDE","AMNEAL","","Approval"
"12/13/2022","IDACIOBLA   #761255","ORIG-1","ADALIMUMAB-AACF","FRESENIUS KABI USA","","Approval"
"12/14/2022","XELODANDA   #020896","SUPPL-44","CAPECITABINE","CHEPLAPHARM","Efficacy","Approval"
"12/14/2022","XELODANDA   #020896","SUPPL-45","CAPECITABINE","CHEPLAPHARM","Efficacy","Approval"
"12/14/2022","XELODANDA   #020896","SUPPL-46","CAPECITABINE","CHEPLAPHARM","Efficacy","Approval"
"12/14/2022","XELODANDA   #020896","SUPPL-47","CAPECITABINE","CHEPLAPHARM","Efficacy","Approval"
"12/14/2022","XELODANDA   #020896","SUPPL-48","CAPECITABINE","CHEPLAPHARM","Efficacy","Approval"
"12/14/2022","XELODANDA   #020896","SUPPL-49","CAPECITABINE","CHEPLAPHARM","Efficacy","Approval"
"12/14/2022","XELODANDA   #020896","SUPPL-50","CAPECITABINE","CHEPLAPHARM","Efficacy","Approval"
"12/14/2022","XELODANDA   #020896","SUPPL-51","CAPECITABINE","CHEPLAPHARM","Efficacy","Approval"
"12/14/2022","METHADONE HYDROCHLORIDEANDA  #040088","SUPPL-10","METHADONE HYDROCHLORIDE","VISTAPHARM","Labeling","Approval"
"12/14/2022","METHADONE HYDROCHLORIDEANDA  #040088","SUPPL-11","METHADONE HYDROCHLORIDE","VISTAPHARM","Labeling","Approval"
"12/14/2022","METHADONE HYDROCHLORIDEANDA  #040088","SUPPL-15","METHADONE HYDROCHLORIDE","VISTAPHARM","Labeling","Approval"
"12/14/2022","METHADONE HYDROCHLORIDEANDA  #040088","SUPPL-18","METHADONE HYDROCHLORIDE","VISTAPHARM","Labeling","Approval"
"12/14/2022","METHADONE HYDROCHLORIDEANDA  #040088","SUPPL-20","METHADONE HYDROCHLORIDE","VISTAPHARM","Labeling","Approval"
"12/14/2022","OXAZEPAMANDA  #072253","SUPPL-42","OXAZEPAM","ACTAVIS ELIZABETH","Labeling","Approval"
"12/14/2022","CLONAZEPAMANDA  #077194","SUPPL-13","CLONAZEPAM","BARR","Labeling","Approval"
"12/14/2022","VORICONAZOLEANDA  #200265","SUPPL-20","VORICONAZOLE","SANDOZ INC","Labeling","Approval"
"12/14/2022","VORICONAZOLEANDA  #200265","SUPPL-21","VORICONAZOLE","SANDOZ INC","Labeling","Approval"
"12/14/2022","LEVOLEUCOVORIN CALCIUMANDA  #207547","SUPPL-1","LEVOLEUCOVORIN CALCIUM","AMNEAL","Labeling","Approval"
"12/14/2022","LEVOLEUCOVORIN CALCIUMANDA  #207547","SUPPL-7","LEVOLEUCOVORIN CALCIUM","AMNEAL","Labeling","Approval"
"12/14/2022","LEVOLEUCOVORIN CALCIUMANDA  #207548","SUPPL-1","LEVOLEUCOVORIN CALCIUM","AMNEAL","Labeling","Approval"
"12/14/2022","LEVOLEUCOVORIN CALCIUMANDA  #207548","SUPPL-5","LEVOLEUCOVORIN CALCIUM","AMNEAL","Labeling","Approval"
"12/14/2022","EPCLUSANDA   #208341","SUPPL-20","SOFOSBUVIR; VELPATASVIR","GILEAD SCIENCES INC","Manufacturing (CMC)","Approval"
"12/14/2022","VEMLIDYNDA   #208464","SUPPL-15","TENOFOVIR ALAFENAMIDE FUMARATE","GILEAD SCIENCES INC","Manufacturing (CMC)","Approval"
"12/14/2022","DEFERIPRONEANDA  #208800","SUPPL-1","DEFERIPRONE","TARO PHARM INDS LTD","Labeling","Approval"
"12/14/2022","DEFERIPRONEANDA  #208800","SUPPL-4","DEFERIPRONE","TARO PHARM INDS LTD","Labeling","Approval"
"12/14/2022","PEMFEXYNDA   #209472","SUPPL-5","PEMETREXED","EAGLE PHARMS","Efficacy","Approval"
"12/14/2022","DICLOFENAC POTASSIUMANDA  #216635","SUPPL-1","DICLOFENAC POTASSIUM","ALKEM LABS LTD","Labeling","Approval"
"12/14/2022","DICYCLOMINE HYDROCHLORIDEANDA  #216736","ORIG-1","DICYCLOMINE HYDROCHLORIDE","RUBICON","","Approval"
"12/15/2022","PEPCID ACNDA   #020325","SUPPL-41","FAMOTIDINE","J AND J CONSUMER INC","Labeling","Approval"
"12/15/2022","NORVIRNDA   #020659","SUPPL-73","RITONAVIR","ABBVIE","Labeling","Approval"
"12/15/2022","NORVIRNDA   #022417","SUPPL-25","RITONAVIR","ABBVIE","Labeling","Approval"
"12/15/2022","LEVOCARNITINEANDA  #075861","SUPPL-11","LEVOCARNITINE","AM REGENT","Manufacturing (CMC)","Approval"
"12/15/2022","ESCITALOPRAM OXALATEANDA  #076765","SUPPL-8","ESCITALOPRAM OXALATE","TEVA PHARMS USA","Labeling","Approval"
"12/15/2022","ESCITALOPRAM OXALATEANDA  #076765","SUPPL-9","ESCITALOPRAM OXALATE","TEVA PHARMS USA","Labeling","Approval"
"12/15/2022","ESCITALOPRAM OXALATEANDA  #076765","SUPPL-11","ESCITALOPRAM OXALATE","TEVA PHARMS USA","Labeling","Approval"
"12/15/2022","ESCITALOPRAM OXALATEANDA  #076765","SUPPL-12","ESCITALOPRAM OXALATE","TEVA PHARMS USA","Labeling","Approval"
"12/15/2022","NORVIRNDA   #209512","SUPPL-8","RITONAVIR","ABBVIE","Labeling","Approval"
"12/15/2022","PERSERIS KITNDA   #210655","SUPPL-10","RISPERIDONE","INDIVIOR INC","Efficacy","Approval"
"12/15/2022","BENDAMUSTINE HYDROCHLORIDENDA   #211530","ORIG-1","BENDAMUSTINE HYDROCHLORIDE","HOSPIRA","Type 5 - New Formulation or New Manufacturer","Approval"
"12/15/2022","VEKLURYNDA   #214787","SUPPL-20","REMDESIVIR","GILEAD SCIENCES INC","Labeling","Approval"
"12/15/2022","CISATRACURIUM BESYLATEANDA  #215517","ORIG-1","CISATRACURIUM BESYLATE","PIRAMAL CRITICAL","","Approval"
"12/15/2022","PLERIXAFORANDA  #215698","ORIG-1","PLERIXAFOR","KINDOS PHARMA CO LTD","","Tentative Approval"
"12/15/2022","BENDAMUSTINE HYDROCHLORIDENDA   #216078","ORIG-1","BENDAMUSTINE HYDROCHLORIDE","BAXTER HLTHCARE CORP","Type 5 - New Formulation or New Manufacturer","Approval"
"12/16/2022","PRECEDEXNDA   #021038","SUPPL-28","DEXMEDETOMIDINE HYDROCHLORIDE","HOSPIRA","Efficacy","Approval"
"12/16/2022","SUBOXONENDA   #022410","SUPPL-48","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","INDIVIOR INC","REMS","Approval"
"12/16/2022","ZOSYNNDA   #050684","SUPPL-101","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS","Labeling","Approval"
"12/16/2022","ZOSYN IN PLASTIC CONTAINERNDA   #050750","SUPPL-49","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","BAXTER HLTHCARE CORP","Labeling","Approval"
"12/16/2022","ARIPIPRAZOLEANDA  #078583","SUPPL-1","ARIPIPRAZOLE","APOTEX INC","Labeling","Approval"
"12/16/2022","ARIPIPRAZOLEANDA  #078583","SUPPL-2","ARIPIPRAZOLE","APOTEX INC","Labeling","Approval"
"12/16/2022","ARIPIPRAZOLEANDA  #078583","SUPPL-4","ARIPIPRAZOLE","APOTEX INC","Labeling","Approval"
"12/16/2022","ARIPIPRAZOLEANDA  #078583","SUPPL-5","ARIPIPRAZOLE","APOTEX INC","Labeling","Approval"
"12/16/2022","ARIPIPRAZOLEANDA  #078583","SUPPL-11","ARIPIPRAZOLE","APOTEX INC","Labeling","Approval"
"12/16/2022","ARIPIPRAZOLEANDA  #078583","SUPPL-12","ARIPIPRAZOLE","APOTEX INC","Labeling","Approval"
"12/16/2022","ARIPIPRAZOLEANDA  #078583","SUPPL-13","ARIPIPRAZOLE","APOTEX INC","Labeling","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #078633","SUPPL-29","BUPRENORPHINE HYDROCHLORIDE","HIKMA","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090279","SUPPL-19","BUPRENORPHINE HYDROCHLORIDE","RUBICON","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090360","SUPPL-24","BUPRENORPHINE HYDROCHLORIDE","BARR","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090622","SUPPL-37","BUPRENORPHINE HYDROCHLORIDE","ETHYPHARM","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090819","SUPPL-28","BUPRENORPHINE HYDROCHLORIDE","ACTAVIS ELIZABETH","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091149","SUPPL-21","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","TEVA PHARMS USA","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091422","SUPPL-49","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ACTAVIS ELIZABETH","REMS","Approval"
"12/16/2022","KEYTRUDABLA   #125514","SUPPL-127","PEMBROLIZUMAB","MERCK SHARP DOHME","","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #201066","SUPPL-20","BUPRENORPHINE HYDROCHLORIDE","MYLAN PHARMS","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #201633","SUPPL-27","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","SUN PHARM","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #201760","SUPPL-29","BUPRENORPHINE HYDROCHLORIDE","SUN PHARM","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #203136","SUPPL-42","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","AMNEAL PHARMS","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #203326","SUPPL-27","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","HIKMA","REMS","Approval"
"12/16/2022","ZUBSOLVNDA   #204242","SUPPL-24","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","OREXO US INC","REMS","Approval"
"12/16/2022","VRAYLARNDA   #204370","SUPPL-9","CARIPRAZINE HYDROCHLORIDE","ABBVIE","Efficacy","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #204431","SUPPL-27","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ETHYPHARM USA CORP","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205022","SUPPL-15","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","LANNETT CO INC","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205299","SUPPL-14","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","DR REDDYS LABS SA","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205601","SUPPL-13","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RHODES PHARMS","REMS","Approval"
"12/16/2022","BUNAVAILNDA   #205637","SUPPL-25","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","BDSI","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205806","SUPPL-13","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","DR REDDYS LABS SA","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205954","SUPPL-22","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ALVOGEN","REMS","Approval"
"12/16/2022","LEVOLEUCOVORIN CALCIUMANDA  #206263","SUPPL-2","LEVOLEUCOVORIN CALCIUM","HIKMA","Labeling","Approval"
"12/16/2022","LEVOLEUCOVORIN CALCIUMANDA  #206263","SUPPL-3","LEVOLEUCOVORIN CALCIUM","HIKMA","Labeling","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #206953","SUPPL-11","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","DR REDDYS LABS SA","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207000","SUPPL-27","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","SPECGX LLC","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #207276","SUPPL-14","BUPRENORPHINE HYDROCHLORIDE","RHODES PHARMS","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207607","SUPPL-15","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","MYLAN TECHNOLOGIES","REMS","Approval"
"12/16/2022","CASSIPANDA   #208042","SUPPL-8","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","TEVA PHARMS USA","REMS","Approval"
"12/16/2022","METHYLPHENIDATE HYDROCHLORIDEANDA  #208737","SUPPL-1","METHYLPHENIDATE HYDROCHLORIDE","CEDIPROF INC","Labeling","Approval"
"12/16/2022","EZETIMIBEANDA  #208803","SUPPL-9","EZETIMIBE","AMNEAL PHARMS CO","Labeling","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #209069","SUPPL-9","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","WES PHARMA INC","REMS","Approval"
"12/16/2022","EZETIMIBE AND SIMVASTATINANDA  #209222","SUPPL-12","EZETIMIBE; SIMVASTATIN","ALKEM LABS LTD","Labeling","Approval"
"12/16/2022","EZETIMIBEANDA  #209234","SUPPL-12","EZETIMIBE","ALKEM LABS LTD","Labeling","Approval"
"12/16/2022","TADALAFILANDA  #210608","SUPPL-1","TADALAFIL","PRINSTON INC","Labeling","Approval"
"12/16/2022","METHYLPHENIDATE HYDROCHLORIDEANDA  #211779","SUPPL-1","METHYLPHENIDATE HYDROCHLORIDE","ALKEM LABS LTD","Labeling","Approval"
"12/16/2022","METHYLPHENIDATE HYDROCHLORIDEANDA  #211779","SUPPL-3","METHYLPHENIDATE HYDROCHLORIDE","ALKEM LABS LTD","Labeling","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #211785","SUPPL-5","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","MYLAN TECHNOLOGIES","REMS","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #212756","SUPPL-2","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","AVEVA","REMS","Approval"
"12/16/2022","CYTALUXNDA   #214907","SUPPL-2","PAFOLACIANINE SODIUM","ON TARGET LABS","Efficacy","Approval"
"12/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #214930","SUPPL-7","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ALKEM LABS LTD","REMS","Approval"
"12/16/2022","CUPRIC SULFATEANDA  #216324","ORIG-1","CUPRIC SULFATE","AM REGENT","","Approval"
"12/16/2022","NICARDIPINE HYDROCHLORIDEANDA  #216357","ORIG-1","NICARDIPINE HYDROCHLORIDE","GLENMARK PHARMS LTD","","Approval"
"12/16/2022","FUROSEMIDEANDA  #216860","ORIG-1","FUROSEMIDE","MANKIND PHARMA","","Approval"
"12/19/2022","ALDACTONENDA   #012151","SUPPL-79","SPIRONOLACTONE","PFIZER","Labeling","Approval"
"12/19/2022","ALDACTAZIDENDA   #012616","SUPPL-83","HYDROCHLOROTHIAZIDE; SPIRONOLACTONE","PFIZER","Labeling","Approval"
"12/19/2022","CLOZARILNDA   #019758","SUPPL-101","CLOZAPINE","HERITAGE LIFE","Labeling","Approval"
"12/19/2022","NAPHCON-ANDA   #020226","SUPPL-35","NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE","ALCON","Labeling","Approval"
"12/19/2022","XALATANNDA   #020597","SUPPL-54","LATANOPROST","UPJOHN","Labeling","Approval"
"12/19/2022","MICARDISNDA   #020850","SUPPL-45","TELMISARTAN","BOEHRINGER INGELHEIM","Labeling","Approval"
"12/19/2022","MICARDIS HCTNDA   #021162","SUPPL-47","HYDROCHLOROTHIAZIDE; TELMISARTAN","BOEHRINGER INGELHEIM","Labeling","Approval"
"12/19/2022","OZURDEXNDA   #022315","SUPPL-16","DEXAMETHASONE","ABBVIE","Labeling","Approval"
"12/19/2022","FLUVOXAMINE MALEATEANDA  #075902","SUPPL-26","FLUVOXAMINE MALEATE","APOTEX","Labeling","Approval"
"12/19/2022","FLUVOXAMINE MALEATEANDA  #075902","SUPPL-27","FLUVOXAMINE MALEATE","APOTEX","Labeling","Approval"
"12/19/2022","CIPROFLOXACINANDA  #076089","SUPPL-44","CIPROFLOXACIN","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACINANDA  #076089","SUPPL-46","CIPROFLOXACIN","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACINANDA  #076089","SUPPL-48","CIPROFLOXACIN","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACINANDA  #076089","SUPPL-49","CIPROFLOXACIN","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACINANDA  #076089","SUPPL-51","CIPROFLOXACIN","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACINANDA  #076089","SUPPL-52","CIPROFLOXACIN","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACINANDA  #076089","SUPPL-53","CIPROFLOXACIN","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076089","SUPPL-44","CIPROFLOXACIN HYDROCHLORIDE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076089","SUPPL-46","CIPROFLOXACIN HYDROCHLORIDE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076089","SUPPL-48","CIPROFLOXACIN HYDROCHLORIDE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076089","SUPPL-49","CIPROFLOXACIN HYDROCHLORIDE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076089","SUPPL-51","CIPROFLOXACIN HYDROCHLORIDE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076089","SUPPL-52","CIPROFLOXACIN HYDROCHLORIDE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076089","SUPPL-53","CIPROFLOXACIN HYDROCHLORIDE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076639","SUPPL-13","CIPROFLOXACIN HYDROCHLORIDE","UNIQUE","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076639","SUPPL-14","CIPROFLOXACIN HYDROCHLORIDE","UNIQUE","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076639","SUPPL-15","CIPROFLOXACIN HYDROCHLORIDE","UNIQUE","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076639","SUPPL-18","CIPROFLOXACIN HYDROCHLORIDE","UNIQUE","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076639","SUPPL-19","CIPROFLOXACIN HYDROCHLORIDE","UNIQUE","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076639","SUPPL-22","CIPROFLOXACIN HYDROCHLORIDE","UNIQUE","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076639","SUPPL-23","CIPROFLOXACIN HYDROCHLORIDE","UNIQUE","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076639","SUPPL-27","CIPROFLOXACIN HYDROCHLORIDE","UNIQUE","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076639","SUPPL-29","CIPROFLOXACIN HYDROCHLORIDE","UNIQUE","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076639","SUPPL-30","CIPROFLOXACIN HYDROCHLORIDE","UNIQUE","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076794","SUPPL-36","CIPROFLOXACIN HYDROCHLORIDE","WATSON LABS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076794","SUPPL-38","CIPROFLOXACIN HYDROCHLORIDE","WATSON LABS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076794","SUPPL-39","CIPROFLOXACIN HYDROCHLORIDE","WATSON LABS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076794","SUPPL-40","CIPROFLOXACIN HYDROCHLORIDE","WATSON LABS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076794","SUPPL-42","CIPROFLOXACIN HYDROCHLORIDE","WATSON LABS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076794","SUPPL-43","CIPROFLOXACIN HYDROCHLORIDE","WATSON LABS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076794","SUPPL-44","CIPROFLOXACIN HYDROCHLORIDE","WATSON LABS","Labeling","Approval"
"12/19/2022","CIPROFLOXACIN HYDROCHLORIDEANDA  #076794","SUPPL-46","CIPROFLOXACIN HYDROCHLORIDE","WATSON LABS","Labeling","Approval"
"12/19/2022","LEVOFLOXACINANDA  #078424","SUPPL-21","LEVOFLOXACIN","LUPIN","Labeling","Approval"
"12/19/2022","JAKAFINDA   #202192","SUPPL-27","RUXOLITINIB PHOSPHATE","INCYTE CORP","Efficacy","Approval"
"12/19/2022","TYMLOSNDA   #208743","SUPPL-13","ABALOPARATIDE","RADIUS HEALTH INC","Efficacy","Approval"
"12/19/2022","POTASSIUM CHLORIDEANDA  #210041","SUPPL-6","POTASSIUM CHLORIDE","AMNEAL","Manufacturing (CMC)","Approval"
"12/19/2022","DROSPIRENONENDA   #216285","SUPPL-2","DROSPIRENONE","EXELTIS USA INC","Labeling","Approval"
"12/19/2022","EMTRICITABINE; TENOFOVIR ALAFENAMIDEANDA  #216875","ORIG-1","EMTRICITABINE;TENOFOVIR ALAFENAMIDE","AUROBINDO PHARMA","","Tentative Approval"
"12/19/2022","ILUMYABLA   #761067","SUPPL-14","TILDRAKIZUMAB-ASMN","SUN PHARMA GLOBAL","","Approval"
"12/19/2022","BEOVUBLA   #761125","SUPPL-17","brolucizumab-dbll","NOVARTIS PHARMS CORP","","Approval"
"12/20/2022","ATOMOXETINE HYDROCHLORIDEANDA  #079016","SUPPL-7","ATOMOXETINE HYDROCHLORIDE","AUROBINDO PHARMA","Labeling","Approval"
"12/20/2022","ATOMOXETINE HYDROCHLORIDEANDA  #079016","SUPPL-8","ATOMOXETINE HYDROCHLORIDE","AUROBINDO PHARMA","Labeling","Approval"
"12/20/2022","CHILDREN'S ALLEGRA ALLERGYNDA   #201373","SUPPL-12","FEXOFENADINE HYDROCHLORIDE","CHATTEM SANOFI","Manufacturing (CMC)","Approval"
"12/20/2022","CHILDREN'S ALLEGRA HIVESNDA   #201373","SUPPL-12","FEXOFENADINE HYDROCHLORIDE","CHATTEM SANOFI","Manufacturing (CMC)","Approval"
"12/20/2022","AVYCAZNDA   #206494","SUPPL-11","AVIBACTAM SODIUM; CEFTAZIDIME","ALLERGAN","Efficacy","Approval"
"12/20/2022","BIMATOPROSTANDA  #207601","SUPPL-1","BIMATOPROST","SOMERSET THERAPS LLC","Labeling","Approval"
"12/20/2022","BIMATOPROSTANDA  #207601","SUPPL-2","BIMATOPROST","SOMERSET THERAPS LLC","Labeling","Approval"
"12/20/2022","BIMATOPROSTANDA  #207601","SUPPL-4","BIMATOPROST","SOMERSET THERAPS LLC","Labeling","Approval"
"12/20/2022","BRINZOLAMIDEANDA  #209406","SUPPL-1","BRINZOLAMIDE","WATSON LABS INC","Labeling","Approval"
"12/20/2022","BIMATOPROSTANDA  #210263","SUPPL-2","BIMATOPROST","ALEMBIC","Labeling","Approval"
"12/20/2022","BIMATOPROSTANDA  #210263","SUPPL-3","BIMATOPROST","ALEMBIC","Labeling","Approval"
"12/20/2022","TASIMELTEONANDA  #211607","ORIG-1","TASIMELTEON","APOTEX","","Approval"
"12/20/2022","AMANTADINE HYDROCHLORIDEANDA  #214580","ORIG-1","AMANTADINE HYDROCHLORIDE","HUMANWELL PURACAP","","Approval"
"12/20/2022","BRIVARACETAMANDA  #214918","ORIG-1","BRIVARACETAM","LUPIN LTD","","Approval"
"12/21/2022","BYETTANDA   #021773","SUPPL-48","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling","Approval"
"12/21/2022","BYDUREONNDA   #022200","SUPPL-34","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling","Approval"
"12/21/2022","BYDUREON PENNDA   #022200","SUPPL-34","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling","Approval"
"12/21/2022","BRIMONIDINE TARTRATEANDA  #078480","ORIG-1","BRIMONIDINE TARTRATE","APOTEX","","Approval"
"12/21/2022","ACTEMRABLA   #125276","SUPPL-138","TOCILIZUMAB","GENENTECH","","Approval"
"12/21/2022","ACTEMRABLA   #125472","SUPPL-49","TOCILIZUMAB","GENENTECH","","Approval"
"12/21/2022","RUBRACANDA   #209115","SUPPL-13","RUCAPARIB CAMSYLATE","CLOVIS ONCOLOGY INC","Efficacy","Approval"
"12/21/2022","BYDUREON BCISENDA   #209210","SUPPL-22","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling","Approval"
"12/21/2022","LEVOTHYROXINE SODIUMANDA  #211417","ORIG-1","LEVOTHYROXINE SODIUM","MACLEODS PHARMS LTD","","Approval"
"12/21/2022","PRETOMANIDNDA   #212862","SUPPL-4","PRETOMANID","MYLAN IRELAND LTD","Labeling","Approval"
"12/21/2022","SELEXIPAGANDA  #214302","ORIG-1","SELEXIPAG","ZYDUS","","Approval"
"12/21/2022","NICOTINE POLACRILEXANDA  #214354","ORIG-1","NICOTINE POLACRILEX","FERTIN PHARMA","","Approval"
"12/21/2022","MYCOPHENOLATE MOFETILANDA  #214525","SUPPL-2","MYCOPHENOLATE MOFETIL","LANNETT CO INC","Labeling","Approval"
"12/21/2022","MYCOPHENOLATE MOFETILANDA  #214525","SUPPL-3","MYCOPHENOLATE MOFETIL","LANNETT CO INC","Labeling","Approval"
"12/21/2022","MYCOPHENOLATE MOFETILANDA  #214525","SUPPL-4","MYCOPHENOLATE MOFETIL","LANNETT CO INC","Labeling","Approval"
"12/21/2022","MYCOPHENOLATE MOFETILANDA  #214871","SUPPL-1","MYCOPHENOLATE MOFETIL","AMNEAL","Labeling","Approval"
"12/21/2022","MYCOPHENOLATE MOFETILANDA  #214871","SUPPL-4","MYCOPHENOLATE MOFETIL","AMNEAL","Labeling","Approval"
"12/21/2022","ARFORMOTEROL TARTRATEANDA  #215385","SUPPL-1","ARFORMOTEROL TARTRATE","SUN PHARM","Labeling","Approval"
"12/21/2022","NAPROXENANDA  #215776","SUPPL-1","NAPROXEN","HETERO LABS LTD III","Labeling","Approval"
"12/21/2022","DOBUTAMINE HYDROCHLORIDEANDA  #216131","ORIG-1","DOBUTAMINE HYDROCHLORIDE","HAINAN POLY","","Approval"
"12/21/2022","LINCOMYCIN HYDROCHLORIDEANDA  #216662","ORIG-1","LINCOMYCIN HYDROCHLORIDE","HAINAN POLY","","Approval"
"12/22/2022","PROGLYCEMNDA   #017425","SUPPL-17","DIAZOXIDE","TEVA BRANDED PHARM","Labeling","Approval"
"12/22/2022","PROGLYCEMNDA   #017453","SUPPL-23","DIAZOXIDE","TEVA BRANDED PHARM","Labeling","Approval"
"12/22/2022","ARTHROTECNDA   #020607","SUPPL-41","DICLOFENAC SODIUM; MISOPROSTOL","PFIZER","Labeling","Approval"
"12/22/2022","ONCASPARBLA   #103411","SUPPL-5205","PEGASPARGASE","SIGMA TAU","","Approval"
"12/22/2022","CIMZIABLA   #125160","SUPPL-305","CERTOLIZUMAB PEGOL","UCB INC","","Approval"
"12/22/2022","DEXTROSE 5% AND LACTATED RINGER'SANDA  #210332","SUPPL-1","CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS KABI USA","Manufacturing (CMC)","Approval"
"12/22/2022","DIMETHYL FUMARATEANDA  #210385","ORIG-1","DIMETHYL FUMARATE","AUROBINDO PHARMA","","Approval"
"12/22/2022","WAKIXNDA   #211150","SUPPL-3","PITOLISANT HYDROCHLORIDE","HARMONY","Labeling","Approval"
"12/22/2022","METHYLPHENIDATE HYDROCHLORIDEANDA  #213473","SUPPL-1","METHYLPHENIDATE HYDROCHLORIDE","DR REDDYS","Labeling","Approval"
"12/22/2022","OLPRUVANDA   #214860","ORIG-1","SODIUM PHENYLBUTYRATE","ACER","Type 5 - New Formulation or New Manufacturer","Approval"
"12/22/2022","FULVESTRANTANDA  #215077","ORIG-1","FULVESTRANT","ALEMBIC","","Approval"
"12/22/2022","SUNLENCANDA   #215973","ORIG-1","LENACAPAVIR SODIUM","GILEAD SCIENCES INC","Type 1 - New Molecular Entity","Approval"
"12/22/2022","SUNLENCANDA   #215974","ORIG-1","LENACAPAVIR SODIUM","GILEAD SCIENCES INC","Type 1 - New Molecular Entity","Approval"
"12/22/2022","POSACONAZOLEANDA  #216626","ORIG-1","POSACONAZOLE","AMNEAL","","Approval"
"12/22/2022","NELARABINEANDA  #216934","ORIG-1","NELARABINE","DR REDDYS","","Approval"
"12/22/2022","LUNSUMIOBLA   #761263","ORIG-1","MOSUNETUZUMAB-AXGB","GENENTECH INC","","Approval"
"12/23/2022","CAVERJECTNDA   #020379","SUPPL-38","ALPROSTADIL","PFIZER","Labeling","Approval"
"12/23/2022","CAVERJECT IMPULSENDA   #021212","SUPPL-18","ALPROSTADIL","PFIZER","Labeling","Approval"
"12/23/2022","PLAN B ONE-STEPNDA   #021998","SUPPL-5","LEVONORGESTREL","FDN CONSUMER","Labeling","Approval"
"12/23/2022","SAVELLANDA   #022256","SUPPL-24","MILNACIPRAN HYDROCHLORIDE","ABBVIE","Labeling","Approval"
"12/23/2022","RANOLAZINEANDA  #209081","ORIG-1","RANOLAZINE","AUROBINDO PHARMA","","Approval"
"12/23/2022","MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #211374","SUPPL-5","MYCOPHENOLATE MOFETIL HYDROCHLORIDE","AMNEAL","Labeling","Approval"
"12/23/2022","MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #211374","SUPPL-6","MYCOPHENOLATE MOFETIL HYDROCHLORIDE","AMNEAL","Labeling","Approval"
"12/23/2022","ALKINDI SPRINKLENDA   #213876","SUPPL-2","HYDROCORTISONE","ETON","Labeling","Approval"
"12/23/2022","XENOVIEWNDA   #214375","ORIG-1","XENON XE-129 HYPERPOLARIZED","POLAREAN","Type 1 - New Molecular Entity","Approval"
"12/23/2022","SILDENAFIL CITRATEANDA  #214773","ORIG-1","SILDENAFIL CITRATE","AUROBINDO PHARMA LTD","","Approval"
"12/23/2022","WEGOVYNDA   #215256","SUPPL-5","SEMAGLUTIDE","NOVO","Efficacy","Approval"
"12/23/2022","CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDEANDA  #215555","SUPPL-1","CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE","AMNEAL","Labeling","Approval"
"12/23/2022","MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #216390","ORIG-1","MYCOPHENOLATE MOFETIL HYDROCHLORIDE","STERISCIENCE","","Approval"
"12/23/2022","DAPTOMYCINANDA  #216445","ORIG-1","DAPTOMYCIN","ASPIRO","","Approval"
"12/23/2022","HADLIMABLA   #761059","SUPPL-7","ADALIMUMAB-BWWD","SAMSUNG BIOEPIS CO LTD","","Approval"
"12/27/2022","CHILDREN'S CLARITINNDA   #021891","SUPPL-43","LORATADINE","BAYER HEALTHCARE LLC","Labeling","Approval"
"12/27/2022","CLARITINNDA   #021891","SUPPL-43","LORATADINE","BAYER HEALTHCARE LLC","Labeling","Approval"
"12/27/2022","RISPERIDONEANDA  #077719","SUPPL-9","RISPERIDONE","PHARM ASSOC","Labeling","Approval"
"12/27/2022","RISPERIDONEANDA  #077719","SUPPL-11","RISPERIDONE","PHARM ASSOC","Labeling","Approval"
"12/27/2022","RISPERIDONEANDA  #077719","SUPPL-12","RISPERIDONE","PHARM ASSOC","Labeling","Approval"
"12/27/2022","RISPERIDONEANDA  #077719","SUPPL-13","RISPERIDONE","PHARM ASSOC","Labeling","Approval"
"12/27/2022","RISPERIDONEANDA  #077719","SUPPL-14","RISPERIDONE","PHARM ASSOC","Labeling","Approval"
"12/27/2022","CHILDREN'S ALLEGRA ALLERGYNDA   #201373","SUPPL-13","FEXOFENADINE HYDROCHLORIDE","CHATTEM SANOFI","Manufacturing (CMC)","Approval"
"12/27/2022","CHILDREN'S ALLEGRA HIVESNDA   #201373","SUPPL-13","FEXOFENADINE HYDROCHLORIDE","CHATTEM SANOFI","Manufacturing (CMC)","Approval"
"12/27/2022","DIVALPROEX SODIUMANDA  #202419","SUPPL-22","DIVALPROEX SODIUM","AUROBINDO PHARMA LTD","Labeling","Approval"
"12/27/2022","DIVALPROEX SODIUMANDA  #202419","SUPPL-25","DIVALPROEX SODIUM","AUROBINDO PHARMA LTD","Labeling","Approval"
"12/27/2022","SOLIFENACIN SUCCINATEANDA  #206817","ORIG-1","SOLIFENACIN SUCCINATE","AUROBINDO PHARMA","","Approval"
"12/27/2022","METHYLPHENIDATE HYDROCHLORIDEANDA  #210818","SUPPL-3","METHYLPHENIDATE HYDROCHLORIDE","ALVOGEN","Labeling","Approval"
"12/27/2022","CarmustineANDA  #214117","ORIG-1","CARMUSTINE","ACCORD HLTHCARE","","Approval"
"12/27/2022","ZINC SULFATEANDA  #216145","ORIG-1","ZINC SULFATE MONOHYDRATE","FRESENIUS KABI USA","","Approval"
"12/27/2022","DICYCLOMINE HYDROCHLORIDEANDA  #217054","ORIG-1","DICYCLOMINE HYDROCHLORIDE","TWI PHARMS","","Approval"
"12/28/2022","PRIMIDONEANDA  #040717","SUPPL-12","PRIMIDONE","IMPAX LABS","Labeling","Approval"
"12/28/2022","METHYLPHENIDATE HYDROCHLORIDEANDA  #211009","SUPPL-2","METHYLPHENIDATE HYDROCHLORIDE","ASCENT PHARMS INC","Labeling","Approval"
"12/28/2022","TRIAZOLAMANDA  #213003","ORIG-1","TRIAZOLAM","ZYDUS PHARMS","","Approval"
"12/28/2022","NEXOBRIDBLA   #761192","ORIG-1","ANACAULASE-BCDB","MEDIWOUND, LTD","","Approval"
"12/28/2022","BRIUMVIBLA   #761238","ORIG-1","UBLITUXIMAB-XIIY","TG THERAPEUTICS, INC","","Approval"
"12/29/2022","PREVACID 24 HRNDA   #022327","SUPPL-31","LANSOPRAZOLE","PERRIGO PHARMA INTL","Labeling","Approval"
"12/29/2022","OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #207804","SUPPL-4","HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","PRINSTON INC","Labeling","Approval"
"12/29/2022","QINLOCKNDA   #213973","SUPPL-4","RIPRETINIB","DECIPHERA PHARMS","Labeling","Approval"
"12/29/2022","DICHLORPHENAMIDEANDA  #215924","ORIG-1","DICHLORPHENAMIDE","TORRENT","","Approval"
"12/30/2022","POTASSIUM CHLORIDEANDA  #214892","ORIG-1","POTASSIUM CHLORIDE","GUARDIAN DRUG","","Approval"
"12/30/2022","AZACITIDINEANDA  #215066","ORIG-1","AZACITIDINE","EUGIA PHARMA","","Approval"
"12/30/2022","PRAZOSIN HYDROCHLORIDEANDA  #215697","ORIG-1","PRAZOSIN HYDROCHLORIDE","MANKIND PHARMA","","Approval"